Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Center for Biologics Evaluation and Research (CBER)

Center for Biologics Evaluation and Research (CBER)

                        CBER Offices & Divisions
          CBER Vision & Mission
          CBER Reports
          CBER Ombudsman
          CBER Product Jurisdiction
          Jobs at the Center for Biologics Evaluation and Research (CBER) Home
          About FDA
          FDA Organization
          Center for Biologics Evaluation and Research (CBER)
          CBER Staff Fellow - Product/Chemistry, Manufacturing and Controls (CMC) ReviewerCenter for Biologics Evaluation and Research (CBER) CBER Staff Fellow - Product/Chemistry, Manufacturing and Controls (CMC) Reviewer
  
  	
    Share
    Post
    Linkedin

    Email
    Print**OFFICE OF THERAPEUTIC PRODUCTS (OTP)  
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)
FOOD AND DRUG ADMINISTRATION (FDA)
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)**

*Become a part of an agency that touches the lives of every American!*

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP), is recruiting multiple Product/Chemistry, Manufacturing and Controls (CMC) Review Scientists as Staff Fellows.

The mission of The Office of Therapeutic Products (OTP) to promote public health through a data-driven process to provide regulatory oversight that helps ensure medical products are safe and effective. OTP oversees the development and regulation of a wide variety of biological products, including cell therapy products, tissue-engineered products, and gene therapy products, plasma protein products derived from blood and their recombinant analogues, and certain medical devices used in the production of these products. In addition to performing regulatory review of product quality, safety and effectiveness, OTP conducts applied scientific research related to the products that it regulates, develops relevant regulatory policies, and supports other agencies and center components involved in ensuring compliance with CBER biologics regulations.

**RESPONSIBILITIES:**The selected candidate will be part of a cutting-edge and fast-paced scientific and regulatory environment. As a Staff Fellow, you will have the opportunity to:

Perform scientific review, interpretation, and documentation of product manufacturing data to evaluate the safety and quality of cell therapy products (e.g., stem cells, functionally mature/differentiated cells, cell-based cancer vaccines, cellular immunotherapies, xenotransplant cells/organs), gene therapy products (e.g., genetically modified cells, viral or nonviral vectors, genome editing, peptide/neoantigen- and gene-based cancer vaccines), tissue engineered products (e.g., cell-seeded scaffolds, tissue constructs, 3D bioprinted tissue-engineered constructs), and/or select medical devices in regulatory submissions to the FDA.
	Contribute to guidance and policy development activities relevant to cell, gene, and tissue engineered therapies and related medical devices.**BASIC QUALIFICATIONS:** This position is multidisciplinary, and applicants will be required to meet the specific qualification requirements of one of the applicable occupational series: General Natural Resources Management and Biological Sciences (RG-0401), Microbiology (RG-0403), Bioengineering and Biomedical Engineering Series (RG-0858).

**ADDITIONAL QUALIFICATIONS:** A Ph.D. or equivalent advanced degree (M.D., D.V.M., or Sc.D., etc.) with a strong research background in cell therapy, cell and stem cell biology, cellular immunology; cancer biology, regenerative medicine, and/or biomedical engineering; or virology, microbiology, biochemistry, molecular biology, genome editing and/or gene therapy is required. Candidates are expected to be proficient in applying relevant scientific knowledge and research experience to support multi-disciplinary scientific and review of regulatory submissions.

**PREFERRED SPECIALIZED EXPERIENCE:** In addition, the candidate must have strong collaborative skills, excellent written and oral communication skills, and evidence of leadership potential. Postdoctoral experience is highly preferred. Also, knowledge of federal regulations applicable to drugs, biologics, and medical devices is helpful but not a requirement for consideration.

**FOREIGN EDUCATION:** If you are using education completed in foreign colleges or universities to meet the qualification requirements, you must show that the education credentials have been evaluated by a private organization that specializes in interpretation of foreign education programs and such education has been deemed equivalent to that gained in an accredited U.S. education program; or full credit has been given for the courses at a U.S. accredited college or university. For further information, visit the *U.S. Department of Education website for Foreign Education Evaluation*.

**SALARY:** Salary is commensurate with education/experience.

**LOCATION:** FDA White Oak Campus in Silver Spring, MD; telework eligible.

**CONDITIONS OF EMPLOYMENT:** This position will be filled through the FDA’s Staff Fellowship Program, with an initial appointment period followed by opportunities for renewal. **Applicants must be a U.S. citizen or lawful permanent resident.** No previous Federal experience is required. Appointment does not confer any entitlement to a position in the competitive service, and during the initial appointment there is no entitlement to Merit Systems Protection Board (MSPB) appeals rights.

One-year probationary period may be required.
	Official Transcripts for all college and graduate school education required.
	Background and/or Security investigation required.
	If applicant is an U.S. Citizen, males born on, or after, December 31st, 1959, must be registered with the Selective Service System or have an approved exemption. Visit the Selective Service System for more info.
	Prohibited financial interest restrictions may apply. For additional information on the prohibited financial interests, please visit the FDA Ethics and Integrity Office webpage.
	Permanent residents are required to have resided in the United States for a **minimum of three of the last five years**.**HOW TO APPLY:** Please submit a statement of interest, Federal Resume*, and a cover letter summarizing relevant experience and indicate your interest in cell therapy, gene therapy or tissue engineering to Manuel.Machin@fda.hhs.gov. Full applications with all supporting documents (i.e., transcripts, names/contact information for three references, proof of U.S. citizenship or lawful permanent residency status, and other supporting documentations) should be submitted by **March 31, 2024**. Applications will be reviewed on a rolling basis. Please reference Job Code: **OTP-23-21-CJP**.

*For more information on what to include in your Federal Resume, please click on the following USAjobs.gov link: https://www.usajobs.gov/help/faq/application/documents/resume/what-to-include/

**ADDITIONAL INFORMATION:** For additional information on CBER Careers, please visit:

*CBER Careers*
	*Scientific Careers at the FDA*

                                                                                  Content current as of:
      11/13/2023
              
              
Regulated Product(s)
		 BiologicsCenter for Biologics Evaluation and Research (CBER)

          
                        CBER Offices & Divisions
          CBER Vision & Mission
          CBER Reports
          CBER Ombudsman
          CBER Product Jurisdiction
          Jobs at CBER
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop